公司2024年度财务报表由中审众环会计师事务所（特殊普通合伙）进行审 计，现将公司2024年度财务决算（合并口径）的相关情况报告如下： 一、2024年度公司财务报表的审计情况 湖北富邦科技股份有限公司 2024 年度财务决算报告 公司2024年度财务会计报表经中审众环会计师事务所（特殊普通合伙）审计， 并出具了"众环审字（2025）0101679号"标准无保留意见的审计报告，认为公 司财务报表在所有重大方面按照企业会计准则的规定编制，公允地反映了公司 2024年12月31日的合并及母公司财务状况，以及2024年度的合并及母公司经营成 果和现金流量。 二、主要财务指标及变动情况 | 项 目 | 2024 年 | 2023 年 | 本年比上年增减 | | --- | --- | --- | --- | | 营业收入 | 123,507.48 | 104,853.16 | 17.79% | | 营业成本 | 89,150.39 | 77,908.69 | 14.43% | | 营业利润 | 12,171.77 | 9,576.51 | 27.10% | | 净利润 | 9,551.54 | 6,667.59 | 4 ...

湖北富邦科技股份有限公司 关于 2024 年度募集资金存放与实际使用情况的专项报告 湖北富邦科技股份有限公司 董事会关于 2024 年度募集资金存放与使用 情况的专项报告 根据中国证监会发布的《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》和深圳证券交易所发布的《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》等有关规定，湖北富邦科技股份有限公司（以下简称"公司"或"本 公司"）董事会编制了截至 2024 年 12 月 31 日止募集资金存放与实际使用情况的专项报告。 经中国证券监督管理委员会于 2018 年 1 月 22 日证监许可 [2018] 44 号文核准，本公司 以 2017 年度权益分派实施完毕后总股本 224,870,098 股为基数测算，按每 10 股配售 3 股的 比例向全体股东配售，拟向原股东配售 67,461,029 股人民币普通股 A 股，本次配股发行价 格为人民币 4.43 元/股，截止 2018 年 6 月 29 日，公司已配售人民币普通股 A 股 66,387,997 股，募集资金总额人民币 294,098,826.71 元，扣除 ...

湖北富邦科技股份有限公司 离任董监高持股及减持承诺事项的说明 湖北富邦科技股份有限公司（以下简称"公司"）第四届董事会独立董事喻 景忠先生自 2019 年 5 月 10 日起担任公司独立董事，连续担任公司独立董事将满 六年。根据《上市公司独立董事管理办法》第十三条"独立董事每届任期与上市 公司其他董事任期相同，任期届满，可以连选连任，但是连续任职不得超过六年"， 喻景忠先生辞去公司独立董事、董事会审计委员会主任委员、董事会薪酬与考核 委员会委员、董事会提名委员会委员职务，辞职后不再担任公司任何职务。 鉴于喻景忠先生的辞职将导致公司独立董事占董事会成员的比例低于三分 之一，董事会审计委员会、提名委员会、薪酬与考核委员会中独立董事未过半数， 且独立董事中欠缺会计专业人士。为保证公司董事会的规范运作，根据《上市公 司独立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创业 板上市公司规范运作》等相关法律法规的规定，喻景忠先生的辞职申请将在公司 股东会选举产生新任独立董事之日后生效。在此之前，喻景忠先生仍将按照相关 法律法规及《湖北富邦科技股份有限公司章程》的规定继续履行公司独立董事及 其在董事会相关 ...

如否，请详细说明：______________________________ 二、本人不存在《中华人民共和国公司法》第一百四十六条等规 定不得担任公司董事的情形。 是 □否 如否，请详细说明：______________________________ 三、本人符合中国证监会《上市公司独立董事管理办法》和深圳 证券交易所业务规则规定的独立董事任职资格和条件。 湖北富邦科技股份有限公司独立董事候选人声明 声明人郭飞作为湖北富邦科技股份有限公司第四届董事会独立 董事候选人，已充分了解并同意由提名人王仁宗提名为湖北富邦科技 股份有限公司（以下简称该公司）第四届董事会独立董事候选人。现 公开声明和保证，本人与该公司之间不存在任何影响本人独立性的关 系，且符合相关法律、行政法规、部门规章、规范性文件和深圳证券 交易所业务规则对独立董事候选人任职资格及独立性的要求，具体声 明并承诺如下事项： 一、本人已经通过湖北富邦科技股份有限公司第四届董事会提名 委员会或者独立董事专门会议资格审查，提名人与本人不存在利害关 系或者其他可能影响独立履职情形的密切关系。 是 □否 是 □否 如否，请详细说明：______________ ...

证券代码：300387 证券简称：富邦科技 公告编号：2025-017 湖北富邦科技股份有限公司 关于召开 2024 年年度股东会的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 根据《湖北富邦科技股份有限公司章程》（以下简称"《公司章程》"）的 有关规定，经湖北富邦科技股份有限公司（以下简称"公司"）第四届董事会第 十一次会议审议通过，决定于 2025 年 5 月 15 日 14:30 在公司会议室召开 2024 年年度股东会，具体通知如下： 一、召开会议的基本情况 1、股东会届次：2024 年年度股东会 2、股东会召集人：公司董事会 （1）现场会议召开时间：2025 年 5 月 15 日（星期四）14:30； （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时 间为：2025 年 5 月 15 日 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证券交 易所互联网投票系统投票的具体时间为：2025 年 5 月 15 日 9:15-15:00 期间的任 意时间。 5、会议召开方式：本次股东会采取现场表决与网络投票 ...

证券代码：300387 证券简称：富邦科技 公告编号：2025-002 湖北富邦科技股份有限公司 第四届监事会第九次会议决议公告 本次会议通知于 2025 年 4 月 10 日以通讯方式发出，会议召开及表决程序符 合《中华人民共和国公司法》（以下简称"《公司法》"）《湖北富邦科技股份 有限公司章程》（以下简称"《公司章程》"）的有关规定。 本次会议由监事会主席周家林先生主持，公司董事、高级管理人员列席了会 议，与会监事经认真审议，以举手表决方式逐项审议如下议案： 一、审议通过《<2024 年年度报告>及其摘要》 经审议，监事会认为：公司《2024 年年度报告》及其摘要的编制和审核程序 符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完整地反映了 公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 具体内容详见公司于同日在巨潮资讯网（https://www.cninfo.com.cn）披露的 《2024 年年度报告》及其摘要。《2024 年年度报告摘要》同时刊登在《中国证 券报》《证券日报》《证券时报》《上海证券报》。 本议案尚需提交公司 2024 年年度股东会审议。 表决结果：3 票同意， ...

本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 湖北富邦科技股份有限公司（以下简称"公司"）第四届董事会第十一次会 议于 2025 年 4 月 21 日以现场结合通讯的方式在公司会议室召开，应出席公司会 议的董事 7 人，实际出席公司会议的董事 7 人，其中董事毛基业先生及独立董事 喻景忠先生、黄巧云先生、叶志彪先生以视频通讯方式出席会议。 本次会议通知于 2025 年 4 月 10 日以通讯方式发出，会议召开及表决程序符 合《中华人民共和国公司法》（以下简称"《公司法》"）及《湖北富邦科技股 份有限公司章程》（以下简称"《公司章程》"）的有关规定。 本次会议由董事长王仁宗先生主持，公司监事、高级管理人员列席了会议， 与会董事经认真审议，以举手表决、通讯表决方式逐项审议如下议案： 证券代码：300387 证券简称：富邦科技 公告编号：2025-001 湖北富邦科技股份有限公司 第四届董事会第十一次会议决议公告 一、审议通过《<2024 年年度报告>及其摘要》 2024 年，公司董事会严格遵守《公司法》《中华人民共和国证券法》（以下 简称"《证券法》"）等法律法规和《 ...

证券代码：300387 证券简称：富邦科技 公告编号：2025-006 独立董事认为：经审议《2024 年度利润分配预案》，我们认为该利润分配预 案符合公司实际情况，没有违反《中华人民共和国公司法》（以下简称"《公司 法》"）《上市公司监管指引第 3 号——上市公司现金分红》及《湖北富邦科技 股份有限公司章程》（以下简称"《公司章程》"）的有关规定，未损害公司股 东尤其是中小股东的利益，有利于公司的正常经营和健康发展。我们一致同意该 议案并将该议案提交董事会审议。 （二）董事会审议情况 公司于 2025 年 4 月 21 日召开第四届董事会第十一次会议，审议通过了《2024 年度利润分配预案》。 湖北富邦科技股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 湖北富邦科技股份有限公司（以下简称"公司"）于 2025 年 4 月 21 日召开了 第四届董事会第十一次会议与第四届监事会第九次会议，分别审议通过了《2024 年度利润分配预案》。本议案尚需提交公司股东会审议，现将有关情况公告如下： 一、本次利润分配预案的审议 ...

Financial Performance - The company's revenue for Q1 2025 was ¥304,877,987.78, a decrease of 3.44% compared to ¥315,727,870.21 in the same period last year[4] - Net profit attributable to shareholders was ¥23,123,042.02, down 11.75% from ¥26,200,443.33 year-on-year[4] - Basic earnings per share decreased to ¥0.0800, down 11.70% from ¥0.0906 in the same period last year[4] - Total operating revenue decreased to CNY 304,877,987.78 from CNY 315,727,870.21, representing a decline of approximately 3.7% year-over-year[21] - Net profit for the period was CNY 24,303,774.57, down from CNY 27,150,657.98, reflecting a decrease of approximately 10.8% year-over-year[22] - The company's weighted average return on equity was 1.67%, a decrease of 0.31% compared to 1.98% in the previous year[4] - The company reported a comprehensive income total of CNY 50,986,275.16, compared to CNY 10,766,830.69 in the previous period, indicating a significant increase[22] Cash Flow - The net cash flow from operating activities was -¥48,356,259.60, a significant decline of 2,340.21% compared to -¥1,981,641.03 in the previous year[4] - Operating cash inflow totaled $304,395,539.51, an increase from $293,625,779.41 in the previous period[24] - Operating cash outflow amounted to $352,751,799.11, compared to $295,607,420.44 last period, resulting in a net cash flow from operating activities of -$48,356,259.60[24] - Investment cash inflow was $60,381,319.22, down from $85,212,438.09 in the prior period, while investment cash outflow reached $62,262,921.04, leading to a net cash flow from investing activities of -$1,881,601.82[24] - Financing cash inflow increased to $73,000,000.00 from $14,800,000.00, with financing cash outflow at $50,465,654.90, resulting in a net cash flow from financing activities of $22,534,345.10[25] - The net increase in cash and cash equivalents was -$24,842,390.67, compared to -$40,641,706.37 last period[25] - The ending balance of cash and cash equivalents stood at $328,334,023.44, up from $253,894,274.56 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,990,268,597.61, an increase of 3.50% from ¥1,922,886,539.75 at the end of the previous year[4] - Total liabilities rose to CNY 550,905,951.12 from CNY 534,510,168.42, an increase of approximately 3.1%[19] - The company's equity attributable to shareholders increased to CNY 1,392,827,227.10 from CNY 1,343,022,884.46, reflecting a growth of about 3.7%[19] - The company's goodwill increased to CNY 485,979,927.24 from CNY 470,270,017.59, an increase of about 3.3%[19] - Long-term borrowings rose to CNY 200,131,000.00 from CNY 166,651,000.00, an increase of approximately 20.0%[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 21,105[10] - The company received government subsidies amounting to ¥758,774.40 during the reporting period, which positively impacted its financial performance[5] - The company has established a professional legal team to address ongoing litigation related to equity payment disputes, ensuring the protection of shareholder rights[15] Strategic Initiatives - The company successfully held a global agricultural cost-reduction and yield-increase technology seminar in March 2025, launching the "Agricultural Doctor" green agriculture brand[14] - The company was recognized as one of the "Top 100 High-tech Enterprises in Hubei Province," enhancing its reputation in innovation and technology[15] - The company plans to change its stock abbreviation to "Fubon Technology" starting January 2, 2025, to better reflect its strategic focus on technological innovation[13] - The company is committed to driving agricultural cost reduction and yield increase through technological innovation and sustainable development strategies[14] - The company aims to deepen its strategic layout in agricultural chemical additives and specialty fertilizers, promoting resource allocation and R&D collaboration[13] Current Assets - The company reported a total current assets of CNY 955,559,576.94 as of March 31, 2025, an increase from CNY 898,195,927.71 at the beginning of the period, representing a growth of approximately 6.7%[17] - Accounts receivable increased to CNY 289,294,451.35 from CNY 236,481,071.65, reflecting a rise of about 22.2%[17] - Inventory levels rose to CNY 199,530,272.51, up from CNY 176,828,870.45, indicating an increase of approximately 12.8%[17] Operating Costs - Total operating costs decreased to CNY 273,936,249.03 from CNY 278,152,630.61, a reduction of about 1.6% year-over-year[21] - Cash received from sales of goods and services was $300,565,753.87, compared to $290,125,971.98 previously[24] - Cash paid for goods and services was $273,961,207.67, an increase from $225,458,423.58 in the prior period[24] - Employee compensation payments totaled $33,319,176.29, up from $27,083,378.06 last period[24]

Financial Performance - The company achieved a total revenue of 1,235.07 million yuan in 2024, representing a year-on-year increase of 17.79%[133]. - Net profit attributable to shareholders was 93.59 million yuan, a year-on-year increase of 30.81%; net profit excluding non-recurring gains and losses was 87.92 million yuan, up 23.91% year-on-year[117]. - The company's agricultural additive business generated revenue of 902.47 million yuan, reflecting a growth of 9.35% year-on-year, and was recognized as the "global fertilizer additive sales leader" by a reputable international organization[118]. - Domestic revenue reached 673.32 million yuan, up 19.21% year-on-year, accounting for 54.52% of total revenue; overseas revenue was 561.76 million yuan, increasing by 16.13% year-on-year, making up 45.48% of total revenue[117]. - The revenue from bio-products surged by 169.05% to ¥206,607,090.49, indicating strong demand and market growth[134]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 0.70 RMB per 10 shares to all shareholders, based on a total of 289,057,018 shares[3]. - The company has not proposed any stock bonus distribution for the current reporting period[3]. - The company emphasizes that all board members attended the meeting to review the annual report, ensuring accountability for the report's accuracy and completeness[3]. Risk Management - The company has stated that there are no significant risks that could materially affect its production and operations during the reporting period[3]. - The company has detailed potential risks faced in its operations in the section titled "Management Discussion and Analysis" under "Future Development Outlook"[3]. Research and Development - In 2024, the company's R&D investment reached 46.85 million yuan, supporting its innovation-driven development strategy and enhancing market competitiveness[105]. - The company has increased its R&D efforts in value-added fertilizers, focusing on developing new products for soil improvement and fertilizer efficiency[50]. - The company is actively collaborating with institutions like China Agricultural University and Huazhong Agricultural University to develop advanced nitrogen-fixing bacteria and optimize their genetic traits using CRISPR-Cas technology[63]. - The company has established a strong R&D team with 169 personnel, including 26 with master's degrees and 5 with doctoral degrees, enhancing its innovation capabilities[103]. Product Development and Innovation - The company is focusing on developing new types of agricultural additives that are more precise, green, efficient, and nutrient-rich, aligning with the industry's shift towards sustainable practices[39]. - The company has successfully developed various value-added fertilizers, including oxygen-releasing fertilizers and customized fertilizers, aimed at enhancing crop yield and quality[51]. - The company aims to develop a new biopesticide with over 70% field efficacy against root knot nematodes, addressing a significant agricultural challenge[150]. - The company is innovating anti-caking agents for water-soluble fertilizers to prevent clogging in irrigation systems[150]. Market Expansion and Strategy - The company is actively expanding its international market presence, with a focus on exporting high-value-added fertilizer products, particularly value-added potassium fertilizers, which have shown a year-on-year increase in sales[95]. - The company aims to enhance its global integrated operations by 2025, focusing on customer demand and optimizing marketing, R&D, production, supply, and logistics systems[189]. - The company plans to deepen its market presence in Asia, Europe, Africa, and the former CIS regions, with a focus on strategic layout and expanding market share[190]. - The company is focusing on building a customized service platform to capture the digital agricultural service market, enhancing customer engagement and service quality[123]. Environmental Commitment - The company is committed to aligning with national policies aimed at reducing fertilizer usage while improving efficiency and environmental sustainability[35]. - The introduction of biological fertilizers is expected to reduce reliance on traditional fertilizers, addressing environmental concerns and improving soil health[54]. - The company is investing in the research and application of biodegradable and environmentally friendly materials, holding numerous patents and proprietary technologies in fertilizer production[76]. Operational Efficiency - The company is focused on advancing its production processes to improve efficiency and product quality in the agricultural sector[84]. - The company has a designed capacity of 23,000 tons per annum for fertilizer anti-caking agents (powder), with a utilization rate of 124.72% and an additional 15,000 tons per annum under construction[85]. - The company has completed construction of a 34,500 tons per annum capacity for fertilizer anti-caking agents (paste), which is currently in normal production[85]. Partnerships and Collaborations - The company has established stable partnerships with over 400 large and medium-sized fertilizer enterprises globally, enhancing its market presence in East Asia, Southeast Asia, Europe, and North Africa[43]. - The company has signed significant sales contracts, with the top five customers contributing ¥403,688,890.40, which is 32.69% of total annual sales[145]. - The company has established stable partnerships with numerous fertilizer manufacturers in domestic and international markets, including YARA and ICL[113]. Financial Management - The company has committed to invest a total of 300 million CNY in various projects, with 285.2 million CNY already utilized, achieving a progress rate of 95.3%[171]. - The total investment amount for the reporting period was ¥79,787,164.92, a decrease of 34.47% compared to ¥121,759,676.52 in the same period last year[163]. - The company has reported goodwill of ¥437.07 million from acquisitions in the Netherlands and France, constituting 31.48% of net assets[158].